Cochrane Abstracts
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems Edited (no change to conclusions)
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antipsychotic Switching for People With Schizophrenia Who Have Neuroleptic‐induced Weight or Metabolic Problems Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435417/all/Antipsychotic_switching_for_people_with_schizophrenia_who_have_neuroleptic‐induced_weight_or_metabolic_problems_Edited__no_change_to_conclusions_. Accessed 15 August 2022.
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435417/all/Antipsychotic_switching_for_people_with_schizophrenia_who_have_neuroleptic‐induced_weight_or_metabolic_problems_Edited__no_change_to_conclusions_. Accessed August 15, 2022.
Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435417/all/Antipsychotic_switching_for_people_with_schizophrenia_who_have_neuroleptic‐induced_weight_or_metabolic_problems_Edited__no_change_to_conclusions_
Antipsychotic Switching for People With Schizophrenia Who Have Neuroleptic‐induced Weight or Metabolic Problems Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2022 August 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435417/all/Antipsychotic_switching_for_people_with_schizophrenia_who_have_neuroleptic‐induced_weight_or_metabolic_problems_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems Edited (no change to conclusions)
ID - 435417
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435417/all/Antipsychotic_switching_for_people_with_schizophrenia_who_have_neuroleptic‐induced_weight_or_metabolic_problems_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
